erythrosine has been researched along with buprenorphine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baba, M; Oishi, R; Saeki, K | 1 |
| Heller, NM; Maher, DP; Walia, D | 1 |
2 other study(ies) available for erythrosine and buprenorphine
| Article | Year |
|---|---|
Enhancement of blood-brain barrier permeability to sodium fluorescein by stimulation of mu opioid receptors in mice.
Topics: Animals; Blood-Brain Barrier; Buprenorphine; Carbon Dioxide; Fluorescein; Fluoresceins; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Mice; Mice, Inbred Strains; Morphine; Narcotics; Pentazocine; Receptors, Opioid; Receptors, Opioid, mu; Time Factors | 1988 |
Suppression of Human Natural Killer Cells by Different Classes of Opioids.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Anesthesia; Buprenorphine; Enkephalin, D-Penicillamine (2,5)-; Fentanyl; Fluoresceins; Humans; Immunosuppression Therapy; K562 Cells; Killer Cells, Natural; Loperamide; Methadone; Morphinans; Morphine; Naloxone; Naltrexone; Succinimides; Toll-Like Receptor 4; Tramadol | 2019 |